Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition

Biochem Biophys Res Commun. 2002 Oct 25;298(2):282-8. doi: 10.1016/s0006-291x(02)02454-3.

Abstract

With the aim to identify events involved in the determination of p53-dependent apoptosis versus growth arrest, we used rat embryo fibroblasts expressing a temperature-sensitive mutant (tsA58) of the SV40 large tumour antigen (LT). Heat-inactivation of LT leads to p53 activation and commitment to a senescent-like state (REtsA15 cell line) or apoptosis (REtsAF cell line). We report that senescence is associated with high levels of the anti-apoptotic Bcl-2 protein and a cell cycle arrest in G1 phase, whereas apoptosis is associated with low levels of Bcl-2 and a cell cycle arrest in G2 phase. Here we show that Bcl-2, which can inhibit apoptosis and proliferation, turns the apoptotic phenotype into a senescent-like phenotype in G2 phase. This result suggests that Bcl-2-dependent inhibition of apoptosis could be crucial for the commitment to replicative senescence, whereas its ability to inhibit G1 progression would not be required.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Cell Line
  • Cellular Senescence*
  • DNA / biosynthesis
  • Fibroblasts / cytology
  • Fibroblasts / metabolism
  • G1 Phase
  • Phenotype
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / physiology*
  • RNA, Messenger / biosynthesis
  • Rats
  • S Phase
  • Temperature
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • DNA